Scotiabank lowered the firm’s price target on Thermo Fisher (TMO) to $605 from $650 and keeps a Sector Perform rating on the shares. While it is not yet clear whether the potential pharma tariffs could become material headwinds for the company, but the firm believes Thermo Fisher remains well positioned to mitigate additional risks while capitalizing on long-term growth opportunities, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- 3 Best Stocks to Buy Now, 4/25/2025, According to Top Analysts
- Thermo Fisher’s Strategic Resilience Amid Macroeconomic Challenges: A Buy Recommendation
- Thermo Fisher price target lowered to $550 from $678 at Morgan Stanley
- Thermo Fisher price target lowered to $500 from $715 at UBS
- Thermo Fisher price target lowered to $525 from $667 at Raymond James
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue